Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sophie Ruiz
The TLR4 Agonist Adjuvant SLA-SE Promotes Functional Mucosal Antibodies Against a Parenterally Delivered ETEC Vaccine
npj Vaccines
Infectious Diseases
Immunology
Pharmacology
Related publications
Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 Agonist, Promotes Potent Systemic and Mucosal Responses to Intranasal Immunization With HIVgp140
PLoS ONE
Multidisciplinary
A Built-In Adjuvant-Engineered Mucosal Vaccine Against Dysbiotic Periodontal Diseases
Mucosal Immunology
Allergy
Immunology
Clostridium Difficile Flagellin FliC: Evaluation as Adjuvant and Use in a Mucosal Vaccine Against Clostridium Difficile
PLoS ONE
Multidisciplinary
Attenuated Shigella Flexneri 2a guaBA Strain CVD 1204 Expressing Enterotoxigenic Escherichia Coli (ETEC) CS2 and CS3 Fimbriae as a Live Mucosal Vaccine Against Shigella and ETEC Infection
Infection and Immunity
Parasitology
Infectious Diseases
Immunology
Microbiology
Preclinical Efficacy of a Trivalent Human FcγRI-Targeted Adjuvant-Free Subunit Mucosal Vaccine Against Pulmonary Pneumococcal Infection
Vaccines
Drug Discovery
Infectious Diseases
Immunology
Pharmacology
Schistosoma Mansoni Antigen Sm-P80: Prophylactic Efficacy Using TLR4 Agonist Vaccine Adjuvant Glucopyranosyl Lipid A-Alum in Murine and Non-Human Primate Models
Journal of Investigative Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Innovative Mucosal Vaccine Formulations Against Influenza a Virus Infections
Frontiers in Immunology
Allergy
Immunology
A TLR4-derived Non-Cytotoxic, Self-Assembling Peptide Functions as a Vaccine Adjuvant in Mice
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Monoacyl Lipopeptide Agonist of Toll-Like Receptor 2 (TLR2) as a Vaccine Adjuvant
Science-Business eXchange
